• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[远端胰腺切除术联合腹腔干切除及外膜下剥离技术治疗局部进展期或交界可切除胰体癌的比较]

[Comparison of distal pancreatectomy with celiac axis resection and sub-adventitial divestment technique for locally advanced or borderline resectable pancreatic body cancer].

作者信息

Huang X M, Yin J, Lu Z P, Chen J M, Cai B B, Wu P F, Jiang K R, Miao Y

机构信息

Pancreas Center,First Affiliated Hospital of Nanjing Medical University,Pancreas Institute,Nanjing Medical University,Nanjing 210029,China.

出版信息

Zhonghua Wai Ke Za Zhi. 2022 May 1;60(5):441-448. doi: 10.3760/cma.j.cn112139-20210824-00390.

DOI:10.3760/cma.j.cn112139-20210824-00390
PMID:35359085
Abstract

To compare the outcomes of modified Appleby procedure and sub-adventitial divestment technique for locally advanced or borderline resectable pancreatic body cancer. A total of consecutive 58 patients(33 males and 25 females) who were diagnosed as locally advanced or borderline resectable pancreatic body cancer and underwent distal pancreatectomy at Pancreas Center, First Affiliated Hospital of Nanjing Medical University between September 2013 and May 2019 were retrospectively reviewed. The age((IQR)) was 62(9)years(range: 43 to 79 years). Thirty-one patients underwent distal pancreatectomy with celiac axis resection (DP-CAR) and 27 patients underwent distal pancreatectomy with sub-adventitial divestment technique(SDT). Perioperative parameters and follow-up data of these patients were analyzed. Quantitative data were compared with Wilcoxon test while categorical variables were compared with χ test or Fisher's exact test. Survival results were estimated by the Kaplan-Meier survival method with a Log-rank test. There were no differences in age,gender,body mass index,abdominal symptoms,comorbidity or preoperative serum CA19-9 between two groups(all >0.05). Obvious preoperative weight loss was more common in the group of SDT(48.1%(13/27) 19.4%(6/31),χ²=5.431,=0.020). Longer operative time(310(123) minutes . 254(137)minutes, =2.277,=0.023),higher rate of combined organ resection(41.9%(13/31) 14.8%(4/27),χ²=5.123,=0.041) and longer postoperative hospital stay(15(10) days 11(5)days,=2.292,=0.022) were observed in the group of DP-CAR. Moreover,rate of overall morbidities was also higher (71.0%(22/31) 29.6%(8/27),χ=9.876,=0.003),implicated by clinically relevant postoperative pancreatic fistula(61.3%(19/31) 29.6%(8/27),χ=5.814,=0.020) in the DP-CAR group. Tumor size of the DP-CAR group was bigger(4.9(1.5)cm 4.0(1.2)cm,=2.343,=0.019) but no difference was seen between the DP-CAR group and SDT group in R0+R1(<1 mm) resection rate (84.0%(21/25) 90.0%(18/20),=0.678) and LNR(12.0(23.0)% . 9.0(18.0)%,=1.238,=0.216),as well as median disease free survival(11.7 months 11.4 months,=0.019,=0.892) and median overall survival(16.3 months 13.7 months,=0.172,=0.679). Both DP-CAR and distal pancreatectomy with SDT are relatively safe and feasible for locally advanced or borderline resectable pancreatic body cancer. Compared with arterial resection,SDT may contribute to lower rates of postoperative complications and shorter duration of hospitalization,but no significant benefit is seen in long-term survival.

摘要

比较改良Appleby手术和外膜下剥离技术治疗局部进展期或交界可切除胰体癌的疗效。回顾性分析2013年9月至2019年5月在南京医科大学第一附属医院胰腺中心诊断为局部进展期或交界可切除胰体癌并接受胰体尾切除术的58例连续患者(男性33例,女性25例)。年龄(四分位间距)为62(9)岁(范围:43至79岁)。31例行联合腹腔干切除的胰体尾切除术(DP-CAR),27例行外膜下剥离技术的胰体尾切除术(SDT)。分析这些患者的围手术期参数和随访数据。定量数据采用Wilcoxon检验进行比较,分类变量采用χ检验或Fisher精确检验进行比较。生存结果采用Kaplan-Meier生存法和Log-rank检验进行估计。两组患者在年龄、性别、体重指数、腹部症状、合并症或术前血清CA19-9方面均无差异(均>0.05)。术前明显体重减轻在SDT组更常见(48.1%(13/27)对19.4%(6/31),χ²=5.431,P=0.020)。DP-CAR组手术时间更长(310(123)分钟对254(137)分钟,t=2.277,P=0.023),联合器官切除率更高(41.9%(13/31)对14.8%(4/27),χ²=5.123,P=0.041),术后住院时间更长(15(10)天对11(5)天,t=2.292,P=0.022)。此外,DP-CAR组总体并发症发生率也更高(71.0%(22/31)对29.6%(8/27),χ²=9.876,P=0.003),临床相关的术后胰瘘发生率更高(61.3%(19/31)对29.6%(8/27),χ²=5.814,P=0.020)。DP-CAR组肿瘤更大(4.9(1.5)cm对4.0(1.2)cm,t=2.343,P=0.019),但DP-CAR组和SDT组在R0+R1(<1mm)切除率(84.0%(21/25)对90.0%(18/20),z=0.678)、淋巴结转移率(12.0(23.0)%对9.0(18.0)%,z=1.238,P=0.216)以及无病生存期中位数(11.7个月对11.4个月,z=0.019,P=0.892)和总生存期中位数(16.3个月对13.7个月,z=0.172,P=0.679)方面无差异。DP-CAR和SDT胰体尾切除术对于局部进展期或交界可切除胰体癌均相对安全可行。与动脉切除相比,SDT可能有助于降低术后并发症发生率和缩短住院时间,但在长期生存方面未观察到显著益处。

相似文献

1
[Comparison of distal pancreatectomy with celiac axis resection and sub-adventitial divestment technique for locally advanced or borderline resectable pancreatic body cancer].[远端胰腺切除术联合腹腔干切除及外膜下剥离技术治疗局部进展期或交界可切除胰体癌的比较]
Zhonghua Wai Ke Za Zhi. 2022 May 1;60(5):441-448. doi: 10.3760/cma.j.cn112139-20210824-00390.
2
Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma.胰体部交界可切除或局部进展期胰腺癌行联合新辅助化疗的整块整块腹腔动脉切除胰体尾切除术的生存影响。
Pancreatology. 2021 Apr;21(3):564-572. doi: 10.1016/j.pan.2021.01.008. Epub 2021 Jan 27.
3
[Distal pancreatectomy with celiac axis resection for pancreatic body cancer: a single center review of 89 consecutive cases].[胰体癌行远端胰腺切除术并腹腔干切除:89例连续病例的单中心回顾]
Zhonghua Wai Ke Za Zhi. 2023 Oct 1;61(10):894-900. doi: 10.3760/cma.j.cn112139-20230327-00123.
4
Distal pancreatectomy with celiac axis resection for carcinoma of the body and tail of the pancreas.胰体尾癌行胰腺体尾部切除联合腹腔干切除术。
World J Surg. 2011 Nov;35(11):2535-42. doi: 10.1007/s00268-011-1245-x.
5
Periarterial and Sub-adventitial Divestment Along with Triangle Operation and RAMPS for Pancreatic Body Cancer.沿胰腺体癌动脉外膜和外膜下剥离联合三角形手术和 RAMPS
Ann Surg Oncol. 2024 Jul;31(7):4688-4690. doi: 10.1245/s10434-024-15303-y. Epub 2024 May 7.
6
Feasibility and safety of distal pancreatectomy with en bloc celiac axis resection (DP-CAR) combined with neoadjuvant therapy for borderline resectable and unresectable pancreatic body/tail cancer.胰体尾交界可切除和不可切除性胰腺癌新辅助治疗联合整块腹腔动脉切除的远端胰腺切除术(DP-CAR)的可行性和安全性。
Langenbecks Arch Surg. 2019 Jun;404(4):451-458. doi: 10.1007/s00423-019-01775-0. Epub 2019 Mar 13.
7
Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study.胰体尾切除术联合整块腹腔动脉切除治疗局部进展期胰头导管腺癌的疗效分析 - 多中心外科组研究
Pancreatology. 2018 Jan;18(1):106-113. doi: 10.1016/j.pan.2017.11.005. Epub 2017 Nov 14.
8
Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: A major procedure for selected patients.改良Appleby手术治疗可切除边缘/局部进展期远端胰腺腺癌:适用于特定患者的主要手术。
J Visc Surg. 2016 Jun;153(3):173-81. doi: 10.1016/j.jviscsurg.2015.11.014. Epub 2016 Jan 13.
9
Robotic and open distal pancreatectomy with celiac axis resection for locally advanced pancreatic body tumors: a single institutional assessment of perioperative outcomes and survival.用于局部晚期胰体肿瘤的机器人辅助及开放远端胰腺切除术联合腹腔干切除术:单机构围手术期结局及生存情况评估
HPB (Oxford). 2016 Oct;18(10):835-842. doi: 10.1016/j.hpb.2016.05.003. Epub 2016 Jul 8.
10
The role of coeliac axis resection in resected ductal adenocarcinoma of the distal pancreas: A result of tumour topography or a prognostic factor?腹腔干轴切除术在远端胰腺导管腺癌切除中的作用:是肿瘤位置的结果还是预后因素?
Pancreatology. 2022 Jan;22(1):112-122. doi: 10.1016/j.pan.2021.11.001. Epub 2021 Nov 3.